本页面由Tiger Trade Technology Pte. Ltd.提供服务

Acumen Pharmaceuticals, Inc.

2.02
-0.1200-5.61%
盘后:2.020.00000.00%16:10 EDT
成交量:29.06万
成交额:59.55万
市值:1.46亿
市盈率:-1.23
高:2.14
开:2.14
低:2.00
收:2.14
52周最高:3.60
52周最低:1.50
股本:7,221.28万
流通股本:3,704.59万
量比:0.53
换手率:0.78%
股息:- -
股息率:- -
每股收益(TTM):-1.6370
每股收益(LYR):-2.0035
净资产收益率:-120.50%
总资产收益率:-45.77%
市净率:2.55
市盈率(LYR):-1.01

数据加载中...

2026/01/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities